Ponoi II Management
Latest statistics and disclosures from Ponoi II Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Ngm Biopharmaceuticals, RVMD, NRIX, RAPT, and represent 100.00% of Ponoi II Management's stock portfolio.
- Ponoi II Management has $38M in assets under management (AUM), dropping by 3.96%.
- Central Index Key (CIK): 0001746488
Tip: Access up to 7 years of quarterly data
Positions held by Ponoi II Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Ponoi II Management
Ponoi II Management holds 4 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ngm Biopharmaceuticals | 44.4 | $17M | 1.3M | 13.08 |
|
|
| Revolution Medicines (RVMD) | 35.3 | $14M | 685k | 19.72 |
|
|
| Nurix Therapeutics (NRIX) | 11.1 | $4.3M | 327k | 13.03 |
|
|
| Rapt Therapeutics (RAPT) | 9.1 | $3.5M | 145k | 24.06 |
|
Past Filings by Ponoi II Management
SEC 13F filings are viewable for Ponoi II Management going back to 2020
- Ponoi II Management 2022 Q3 filed Nov. 14, 2022
- Ponoi II Management 2022 Q2 filed Aug. 12, 2022
- Ponoi II Management 2022 Q1 filed May 16, 2022
- Ponoi II Management 2021 Q4 filed Feb. 11, 2022
- Ponoi II Management 2021 Q3 filed Nov. 12, 2021
- Ponoi II Management 2021 Q2 filed Aug. 16, 2021
- Ponoi II Management 2021 Q1 filed May 17, 2021
- Ponoi II Management 2020 Q4 filed Feb. 16, 2021